Using integrated results from our GWAS and TWAS findings, we identified an upstream mechanism of yet unknown relevance: higher PPP1R37 gene expression was associated with reduced G-CSF/CSF-3 levels and lower risk of asthma. Here, PPP1R37 is linked to asthma.